tiprankstipranks
Trending News
More News >
Altimmune Inc (ALT)
NASDAQ:ALT

Compare Altimmune (ALT) vs. Competitors

Compare
3,595 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Altimmune
$5.10
$534.23M
-4.77
-20.00%
4 Buy
1 Hold
0 Sell
Strong Buy
Tvardi Therapeutics
$3.90
$38.09M
-0.40
-73.59%
2 Buy
3 Hold
0 Sell
Moderate Buy
Diamedica Therapeutics
$8.47
$439.53M
-11.81
37.44%
4 Buy
0 Hold
0 Sell
Strong Buy
Alpha Tau Medical Ltd
$5.84
$648.01M
-13.88
82.63%
3 Buy
0 Hold
0 Sell
Strong Buy
enGene Holdings
$10.27
$683.24M
-4.48
34.23%
8 Buy
1 Hold
0 Sell
Strong Buy
Lexeo Therapeutics, Inc.
$7.57
$543.03M
-2.80
41.14%
5 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
ALT
Altimmune
5.60
-1.04
-15.66%
TVRD
Tvardi Therapeutics
3.97
-10.55
-72.66%
DMAC
Diamedica Therapeutics
8.04
2.28
39.58%
DRTS
Alpha Tau Medical Ltd
6.94
3.24
87.57%
ENGN
enGene Holdings
9.53
2.83
42.24%
LXEO
Lexeo Therapeutics, Inc.
7.41
1.98
36.46%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts